Medicare AdvantageAdministrativeLow impact
MA06.004d, In Vivo Allergy Sensitivity Testing
Independence Blue Cross·Allergy & Immunology, Family Medicine, Internal Medicine +1 more·Medical Policy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA06.004d for In Vivo Allergy Sensitivity Testing has been reissued with an effective date of April 1, 2026. This is a policy reissue rather than a new policy change, indicating the existing coverage guidelines for allergy testing procedures remain in effect.
Action Required
By April 1, 2026: Billing team should review the updated MA06.004d policy document for any changes to coverage criteria for in vivo allergy sensitivity testing procedures. Verify current prior authorization requirements and billing guidelines remain accurate in billing system for Medicare Advantage members.